Spine BioPharma’s Phase 3 Trial for SB-01 in Chronic Low Back Pain Misses Primary Endpoint

August 2, 2025

Janssen reports positive topline results for Tremfya in Crohn’s at week 48

April 23, 2022

Vertex scores FDA nod for kids’ cystic fibrosis drug Trikafta

June 16, 2021

Must Read

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

April 18, 2026

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

April 18, 2026

BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran

April 18, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Travere’s Filspari becomes the first FDA-approved medication for FSGS

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

Revolution Meets Key Survival Goals With RAS Inhibitor In Important Trial

Tepezza Sales Dip Slightly as Subcutaneous Formulation Shows Late-Stage Efficacy

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran

Regeneron Partners with Telix in Radiopharmaceutical Collaboration Covering Up to Eight Cancer Programs

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

Why Is Market Access Becoming More Difficult for Pharma Companies?

Launch Readiness in Pharma: Overcoming Market Entry Barriers

Tag: Keebler

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

Editor Picks

Spine BioPharma’s Phase 3 Trial for SB-01 in Chronic Low Back Pain Misses Primary Endpoint

Janssen reports positive topline results for Tremfya in Crohn’s at week 48

Vertex scores FDA nod for kids’ cystic fibrosis drug Trikafta

Must Read

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran

Hot Topics

About Us

Follow Us